MARATTO

article · Biochemical Pharmacology

Protective role of dibenzylideneacetone derivative (MBK2) against diabetic pathophysiology via PTGS2-PGE2 signaling modulation and redox homeostasis

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • NF-κB Signaling Pathways
  • Natural Antidiabetic Agents Studies
  • Peroxisome Proliferator-Activated Receptors

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.bcp.2025.117526

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.